The present invention relates uses of an S1 P receptor modulator such as 2-substituted 2-amino-propane-1,3-diol or 2-1 mino-propanol derivatives, e.g. a compound comprising a group of formula (X) for the treatment or prevention of a neo-angiogenesis associated with a demyelinating disease.
